NEW YORK, June 28, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
This report analyzes the worldwide markets for Pain Management in US$ Million by the following Product Segments: Pain Management Pharmaceuticals, Pain Management Devices, and Pain Management Services. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 117 companies including many key and niche players such as AstraZeneca PLC, Eli Lilly and Company, Endo Pharmaceuticals, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Inc., Novartis Pharmaceuticals Corp., Pfizer, Inc., Wyeth, Purdue Pharma, and Sanofi S.A. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definition and Scope of Study I-3
Pain Management Pharmaceuticals I-3
Pain Management Devices I-3
Pain Management Services I-3
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW II-1
Copyright©2012 PR Newswire.
All rights reserved